XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To confirm the efficacy and safety of XELOX with capecitabine maintenance in treatment of
elderly advanced gastric cancer (AGC) by comparing it with that of XELOX regimen.